Extended-spectrum beta lactamase by ceftazidime to ceftazidime clavulanate inhibitory concentration ratio:Imp:Pt:Stool:Ord:Based on lab data

Preferred Label : Extended-spectrum beta lactamase by ceftazidime to ceftazidime clavulanate inhibitory concentration ratio:Imp:Pt:Stool:Ord:Based on lab data;

LOINC status : ACTIVE;

LOINC display name : ESBL by ceftazidime to ceftazidime-clavulanate IC ratio based on lab data Ql (Stl) [Interp];

LOINC long common name : Bacteria.extended spectrum beta lactamase (ESBL) [Presence] in Stool based on lab data;

LOINC short name : Bacteria.ESBL Stl Ql lab data;

Détails

Origin ID

102121-1;

UMLS CUI

C5832398;

Has component
- Beta lactamase [LOINC component]
- Clavulanate [LOINC component]
- Concentration [LOINC component]
- ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [LOINC component]
- cefTAZidime [LOINC component]
- cefTAZidime+Clavulanate [LOINC component]
Has method
- based on lab data [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Stool [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients